DIA Global 2024

It is time to accelerate your drug development

The time has come to streamline your drug development journey from research through commercialization and beyond. Our customers are tapping into our clinical research services, advanced data and technology, along with Thermo Fisher Scientific services to make every moment count in clinical research.

Visit us at our newly refreshed booth space #1327 to find out how you can accelerate your speed to market.

Request a meeting with us

Learn actionable strategies to optimize your drug development in our thought leadership presentation:

Accelerating drug development through the convergence of real-world data (RWD) and technology

Monday, June 17, 2024

12:55-1:25 p.m.

Innovation Theater #2, in the exhibit hall

The proliferation of RWD sources and advancements in technology, such as artificial intelligence (AI) and wearables have fueled the use of real-world evidence (RWE) in drug development. Globally diverse, trusted data sources and impactful AI and digital technologies provide faster, more comprehensive curated data for optimized study design and analysis. This intersection provides invaluable insights to help decision makers make smarter, faster decisions to advance and optimize product development.

Moderator:

Peter Wahl, MLA, MS, ScD, vice president, global head of scientific affairs, CorEvitas, part of the PPD™ clinical research business of Thermo Fisher Scientific

Panelists:

Ariel Berger, MPH, executive director, integrated solutions, real-world evidence Evidera, the peri- and post-approval business of Thermo Fisher Scientific
Gino Pirri, vice president product and technology, the PPD clinical research business of Thermo Fisher Scientific
John Van Hoy, MBA, executive director, data science & advanced analytics, the PPD clinical research business of Thermo Fisher Scientific